None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Yongin Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) 19 years of age or older (2) Clinical evidence of coronary artery disease, including asymptomatic ischemia, stable angina, and acute coronary syndrome (unstable angina, non-ST segmented elevated myocardial infarction, ST segmented elevated myocardial infarction) (3) Unlimited vessel numbers, lesion variables, and lesion length (4) A person who voluntarily agrees to participate in this clinical study;
Exclusion criteria
Exclusion criteria: (1) Life expectancy within one year (2) Persons with known intolerance of the following drugs or substances: heparin, aspirin, clopidogrel, prasugrel, ticagrelor; (3) If other researchers find it inappropriate to participate in this research,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of targeted lesion failures (combination of cardiac death, targeted vascular myocardial infarction, targeted lesion revascularization) | — |
Secondary
| Measure | Time frame |
|---|---|
| One-year major cardiac problems (all cause of death, myocardial infarction, stent thrombosis, target lesion revascularization).;Incidence rate of cardiac death in one year;Incidence of non-cardiac deaths in a year.;Incidence of target vessel myocardial infarction in a year.;Incidence of non-target vessel myocardial infarction in a year.;One-year ischemic-induced target lesion revascularization;One-year non-ischemic-inducing target lesion revascularization;Incidence of acute stent thrombosis within 24 hours, subacute stent thrombosis within 30 days, and late stent thrombosis for one year;a one-year stroke;Annual Bleeding Rate;Reassess primary/secondary efficacy of antiplatelet drugs | — |
Countries
Korea, Republic of
Contacts
Public ContactDeokKyu DeokKyu
Yonsei University Yongin Severance Hospital
Outcome results
None listed